The chemical class termed Synaptotagmin II Activators represents a diverse and intricate group of compounds that interact with cellular mechanisms and pathways indirectly associated with the regulation and function of Synaptotagmin II. Synaptotagmin II is a key protein implicated in the process of neurotransmitter release at synapses, primarily acting as a calcium sensor and playing a crucial role in synaptic vesicle trafficking. The chemicals identified as indirect activators do not bind directly to Synaptotagmin II but influence its activity through modulation of various cellular processes and signaling cascades. These compounds achieve their effects by altering the intracellular milieu or the signaling pathways that converge on the synaptic vesicle fusion process, where Synaptotagmin II operates.
For instance, calcium chloride, being an essential calcium salt, impacts calcium-dependent pathways, thereby influencing the role of Synaptotagmin II in neurotransmitter release. Similarly, compounds like Phorbol 12-myristate 13-acetate (PMA) and Forskolin exert their effects through the activation of protein kinase C and elevation of cAMP levels, respectively, both of which are crucial for the modulation of synaptic vesicle dynamics. Other members of this group, such as GTPγS, a non-hydrolyzable GTP analog, and Okadaic Acid, a protein phosphatase inhibitor, indirectly affect the regulatory mechanisms that could potentially modify Synaptotagmin II activity. Moreover, compounds like BAPTA-AM, Nifedipine, and various calcium channel blockers like Tetrodotoxin, ω-Conotoxin GVIA, and ω-Agatoxin IVA, modulate calcium influx or chelate intracellular calcium, thereby influencing the calcium-dependent regulatory role of Synaptotagmin II. Additionally, agents like Ryanodine and Thapsigargin, which affect calcium release from internal stores, further underscore the complex and interconnected nature of this chemical class in modulating synaptic transmission processes. Collectively, these compounds, by impacting various signaling molecules and pathways, facilitate an environment that influences the functional dynamics of Synaptotagmin II in synaptic vesicle fusion and neurotransmitter release, albeit indirectly and through a complex network of cellular interactions.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Calcium chloride anhydrous | 10043-52-4 | sc-207392 sc-207392A | 100 g 500 g | $66.00 $262.00 | 1 | |
As an essential calcium salt, it can modulate calcium-dependent pathways, indirectly influencing Synaptotagmin II's role in neurotransmitter release. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates protein kinase C, which can modulate synaptic vesicle trafficking and potentially affect Synaptotagmin II function. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Elevates cAMP levels, indirectly affecting pathways that could influence Synaptotagmin II's role in synaptic vesicle fusion. | ||||||
Guanosine 5′-O-(3-thiotriphosphate) tetralithium salt | 94825-44-2 | sc-202639 | 10 mg | $465.00 | ||
A non-hydrolyzable GTP analog, influencing G-protein signaling pathways that could indirectly modulate Synaptotagmin II activity. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $458.00 | 61 | |
A cell-permeable calcium chelator, indirectly affecting calcium-dependent processes involving Synaptotagmin II. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $59.00 $173.00 | 15 | |
As a calcium channel blocker, it can modulate calcium influx, indirectly influencing Synaptotagmin II's calcium-dependent activity. | ||||||
ω-Agatoxin IVA | 145017-83-0 | sc-302015 | 100 µg | $463.00 | ||
A P/Q-type calcium channel blocker, potentially modifying calcium influx and indirectly influencing Synaptotagmin II's function. | ||||||
Ryanodine | 15662-33-6 | sc-201523 sc-201523A | 1 mg 5 mg | $223.00 $799.00 | 19 | |
Modulates the release of calcium from sarcoplasmic/endoplasmic reticulum, potentially affecting calcium-dependent processes involving Synaptotagmin II. | ||||||